Author

M. Moussa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Zarubica· 1 shared A. Zuo· 1 shared B. Malissen· 1 shared C. Dong· 1 shared C. Gregoire· 1 shared C. J. Cooper· 1 shared E. J. Fertig· 1 shared J. C. Smith· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Zarubica

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Viral infection engenders bona fide and bystander lung memory B cell subsets through permissive selection

C. Gregoire, L. Spinelli, S. Villazala-Merino, L. Gil, M. Moussa, C. Dong, A. Zarubica, M. Fallet, J.-M. Navarro, B. Malissen, P. Milpied, M. Gaya

The paper identifies two distinct lung memory B cell subsets post-viral infection, showing they arise from different progenitors and are classified as virus-specific or bystander based on antigen specificity.

bioRxiv · Dec 14, 2021 · PreprintImmunology

Immune Selection Pressure Contributes to Pancreatic Cancer Immune Evasion

R. Ajina, A. Zuo, S. Wang, M. Moussa, C. J. Cooper, Y. Shen, Q. R. Johnson, J. M. Parks, J. C. Smith, M. Catalfamo, E. J. Fertig, S. A. Jablonski, L. M. Weiner

This study shows immune selection pressure in pancreatic cancer drives myeloid mimicry and immune evasion, which can be counteracted by JAK/STAT pathway inhibition to enhance immunotherapy.

bioRxiv · Jun 15, 2020 · PreprintCancer Biology